Galapagos initiates Phase 1 trial for second Toledo compound

Galapagos initiates Phase 1 trial for second Toledo compound - GlobeNewswire

September 24, 2019

Galapagos initiates Phase 1 trial for second Toledo compound GlobeNewswire

Mechelen, Belgium; 24 September 2019, 22.01 CET – Galapagos NV (Euronext & NASDAQ: GLPG) started a Phase 1 trial with GLPG3970, a second generation ...

Rheumatoid Arthritis Pathophysiology

Galapagos initiates Phase 1 trial for second Toledo compound - GlobeNewswire

Comments

Post a Comment

Popular posts from this blog

Understanding Pulmonary Fibrosis - Hour Detroit Magazine

US revokes emergency use of malaria drugs versus coronavirus - KSTP

What’s next for rheumatoid arthritis and cannabis? - The GrowthOp